Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep 3;56(3):2000521.
doi: 10.1183/13993003.00521-2020. Print 2020 Sep.

Artificial intelligence techniques in asthma: a systematic review and critical appraisal of the existing literature

Affiliations
Free article

Artificial intelligence techniques in asthma: a systematic review and critical appraisal of the existing literature

Konstantinos P Exarchos et al. Eur Respir J. .
Free article

Abstract

Artificial intelligence (AI) when coupled with large amounts of well characterised data can yield models that are expected to facilitate clinical practice and contribute to the delivery of better care, especially in chronic diseases such as asthma.The purpose of this paper is to review the utilisation of AI techniques in all aspects of asthma research, i.e. from asthma screening and diagnosis, to patient classification and the overall asthma management and treatment, in order to identify trends, draw conclusions and discover potential gaps in the literature.We conducted a systematic review of the literature using PubMed and DBLP from 1988 up to 2019, yielding 425 articles; after removing duplicate and irrelevant articles, 98 were further selected for detailed review.The resulting articles were organised in four categories, and subsequently compared based on a set of qualitative and quantitative factors. Overall, we observed an increasing adoption of AI techniques for asthma research, especially within the last decade.AI is a scientific field that is in the spotlight, especially the last decade. In asthma there are already numerous studies; however, there are certain unmet needs that need to be further elucidated.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: K.P. Exarchos has nothing to disclose. Conflict of interest: M. Beltsiou has nothing to disclose. Conflict of interest: C-A. Votti has nothing to disclose. Conflict of interest: K. Kostikas reports grants, personal fees and non-financial support from AstraZeneca, Boehringer Ingelheim, Chiesi, ELPEN, GSK, Menarini and Novartis, grants from NuvoAir, personal fees from Sanofi, outside the submitted work; and was an employee and shareholder of Novartis Pharma AG until October 2018.

Publication types